Rocket Pharmaceuticals (RCKT) Other financing activities (2015 - 2020)
Rocket Pharmaceuticals' (RCKT) quarterly Other financing activities came in at $139000.0 in Q2 2020, up 41.84% quarter-over-quarter from $98000.0 in Q1 2020.
Rocket Pharmaceuticals (RCKT) Other financing activities (2015 - 2020) Analysis & Trends
Rocket Pharmaceuticals has disclosed Other financing activities across 3 years of filings, most recently posting $139000.0 for Q2 2020.
- Other financing activities for Q2 2020 came in at $139000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $139000.0 (up 41.84% YoY), and the FY2020 annual result was $237000.0, changed N/A from the prior year.
- Other financing activities came in at $139000.0 for Q2 2020 at Rocket Pharmaceuticals, up from $98000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $139000.0 in Q2 2020 to a low of -$3.2 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Rocket Pharmaceuticals | 296.03 Mn | 296.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 139,000.00 |
| Jun 30, 2020 | 139,000.00 |
| Mar 31, 2020 | 98,000.00 |
| Mar 31, 2020 | 98,000.00 |
| Dec 31, 2017 | -3.25 Mn |
| Dec 31, 2017 | -3.25 Mn |
| Mar 31, 2015 | 1.84 Mn |
| Mar 31, 2015 | 1.84 Mn |